RxDoctor Payments Data

Priscilla Benner, MD

Internal Medicine · Pennsburg, PANPI 1629078936

Payments from drug & device makers

$3,128in general payments, 2019–2025

Across 184 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$974
  • Novo Nordisk$334
  • Lilly USA, LLC$237
  • AstraZeneca$199
  • Sunovion Pharmaceuticals Inc.$143
  • Johnson & Johnson$133
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,128 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$252,036
Medicare patients
351
Services billed
2,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban102$102,316
MounjaroTirzepatide55$64,830
XareltoRivaroxaban72$57,493
JanuviaSitagliptin Phosphate30$46,588
Invega SustennaPaliperidone Palmitate12$29,348
JardianceEmpagliflozin33$28,431
OzempicSemaglutide17$26,506
Rufinamide12$13,346
AbrysvoRsv Vacc, Pref A And Pref B/Pf30$9,495
Clobazam22$8,094
ShingrixVaricella-Zoster Ge/As01b/Pf30$6,666
Atrovent HfaIpratropium Bromide12$6,033
TradjentaLinagliptin18$5,994
Incruse ElliptaUmeclidinium Bromide13$5,614
Fluticasone Propionate HfaFluticasone Propionate15$5,606

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$86$111,811132 claims
Johnson & JohnsonXarelto, Invega Sustenna$133$86,84184 claims
Lilly USA, LLCMounjaro$237$64,83055 claims
MerckJanuvia$72$46,58830 claims
Boehringer IngelheimJardiance, Tradjenta$71$34,42651 claims
Novo NordiskOzempic$334$26,50617 claims
GSKShingrix, Incruse Ellipta$45$12,28043 claims
AbbVieSynthroid$974$4,73467 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.

Other internal medicine in Pennsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →